| USD millions | FY2022 | FY2023 | FY2024 | FY2024 | FY2026 | FY2026 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.4 | 7.3 | 13.5 | 8.8 | 5.3 | 0.3 | 0.3 | +6.2% | |
| Cost of revenue | 1.5 | 1.2 | 4.3 | 2.9 | 2.1 | 0.1 | 1.0 | +654.8% | |
| Gross profit | 2.0 | 6.0 | 9.2 | 5.9 | 3.2 | 0.2 | 0.2 | +0.0% | |
| Research & development | 3.2 | 6.2 | 8.8 | 5.5 | 1.1 | 2.3 | 2.3 | +0.0% | |
| Operating expenses | 7.9 | 12.4 | 38.0 | 12.5 | 4.6 | 15.8 | 15.8 | +0.0% | |
| Operating income | (6.0) | (6.3) | (28.8) | (6.6) | (2.7) | (5.0) | โ | โ | |
| Interest expense | 0.2 | โ | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Pre-tax income | โ | โ | (28.6) | (6.4) | (1.2) | (15.4) | โ | โ | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | โ | โ | |
| Net income | (6.1) | (6.0) | (28.6) | (6.4) | (2.6) | (16.6) | (16.6) | +0.0% | |
| EPS, basic (per share) | (0.84) | (0.51) | (2.05) | (0.38) | (1.04) | (6.33) | โ | โ | |
| EPS, diluted (per share) | โ | (0.51) | (2.05) | (0.38) | (1.04) | (6.33) | โ | โ | |
| EBITDA | (5.9) | (5.8) | (26.6) | (5.3) | (2.4) | (4.9) | โ | โ | |
| Depreciation & amortization | 0.0 | 0.5 | 2.2 | 1.4 | 0.4 | 0.1 | 0.1 | +0.0% | |
| Weighted average shares (shares) | 7,259,249 | 11,731,383 | 13,929,135 | 16,681,234 | 2,454,171 | 2,643,559 | โ | โ | |
| Weighted average diluted shares (shares) | โ | 11,731,383 | 13,929,135 | 16,681,234 | 2,454,171 | 2,643,559 | โ | โ | |
| Gross margin | 57.3% | 82.9% | 68.4% | 66.6% | 61.0% | 57.4% | 54.0% | โ3.3 pts | |
| Operating margin | โ173.9% | โ87.3% | โ213.7% | โ75.1% | โ52.1% | โ1,546.9% | โ | โ | |
| Net margin | โ178.0% | โ82.1% | โ211.9% | โ72.6% | โ48.5% | โ5,150.5% | โ4,850.1% | +300.3 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.